A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion
© 2024. The Author(s)..
Vaccination with infectious Plasmodium falciparum (Pf) sporozoites (SPZ) administered with antimalarial drugs (PfSPZ-CVac), confers superior sterilizing protection against infection when compared to vaccination with replication-deficient, radiation-attenuated PfSPZ. However, the requirement for drug administration constitutes a major limitation for PfSPZ-CVac. To obviate this limitation, we generated late liver stage-arresting replication competent (LARC) parasites by deletion of the Mei2 and LINUP genes (mei2-/linup- or LARC2). We show that Plasmodium yoelii (Py) LARC2 sporozoites did not cause breakthrough blood stage infections and engendered durable sterilizing immunity against various infectious sporozoite challenges in diverse strains of mice. We next genetically engineered a PfLARC2 parasite strain that was devoid of extraneous DNA and produced cryopreserved PfSPZ-LARC2. PfSPZ-LARC2 liver stages replicated robustly in liver-humanized mice but displayed severe defects in late liver stage differentiation and did not form liver stage merozoites. This resulted in complete abrogation of parasite transition to viable blood stage infection. Therefore, PfSPZ-LARC2 is the next-generation vaccine strain expected to unite the safety profile of radiation-attenuated PfSPZ with the superior protective efficacy of PfSPZ-CVac.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
EMBO molecular medicine - 16(2024), 4 vom: 09. Apr., Seite 723-754 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Goswami, Debashree [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Genetically Attenuated Parasite Vaccine |
|---|
| Anmerkungen: |
Date Completed 17.04.2024 Date Revised 25.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s44321-024-00057-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370043669 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370043669 | ||
| 003 | DE-627 | ||
| 005 | 20240425233243.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240323s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s44321-024-00057-7 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1386.xml |
| 035 | |a (DE-627)NLM370043669 | ||
| 035 | |a (NLM)38514791 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Goswami, Debashree |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.04.2024 | ||
| 500 | |a Date Revised 25.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024. The Author(s). | ||
| 520 | |a Vaccination with infectious Plasmodium falciparum (Pf) sporozoites (SPZ) administered with antimalarial drugs (PfSPZ-CVac), confers superior sterilizing protection against infection when compared to vaccination with replication-deficient, radiation-attenuated PfSPZ. However, the requirement for drug administration constitutes a major limitation for PfSPZ-CVac. To obviate this limitation, we generated late liver stage-arresting replication competent (LARC) parasites by deletion of the Mei2 and LINUP genes (mei2-/linup- or LARC2). We show that Plasmodium yoelii (Py) LARC2 sporozoites did not cause breakthrough blood stage infections and engendered durable sterilizing immunity against various infectious sporozoite challenges in diverse strains of mice. We next genetically engineered a PfLARC2 parasite strain that was devoid of extraneous DNA and produced cryopreserved PfSPZ-LARC2. PfSPZ-LARC2 liver stages replicated robustly in liver-humanized mice but displayed severe defects in late liver stage differentiation and did not form liver stage merozoites. This resulted in complete abrogation of parasite transition to viable blood stage infection. Therefore, PfSPZ-LARC2 is the next-generation vaccine strain expected to unite the safety profile of radiation-attenuated PfSPZ with the superior protective efficacy of PfSPZ-CVac | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Genetically Attenuated Parasite Vaccine | |
| 650 | 4 | |a Liver Stage | |
| 650 | 4 | |a Malaria | |
| 650 | 4 | |a Pre-erythrocytic | |
| 650 | 4 | |a Sporozoite | |
| 650 | 7 | |a Malaria Vaccines |2 NLM | |
| 650 | 7 | |a Vaccines, Attenuated |2 NLM | |
| 700 | 1 | |a Patel, Hardik |e verfasserin |4 aut | |
| 700 | 1 | |a Betz, William |e verfasserin |4 aut | |
| 700 | 1 | |a Armstrong, Janna |e verfasserin |4 aut | |
| 700 | 1 | |a Camargo, Nelly |e verfasserin |4 aut | |
| 700 | 1 | |a Patil, Asha |e verfasserin |4 aut | |
| 700 | 1 | |a Chakravarty, Sumana |e verfasserin |4 aut | |
| 700 | 1 | |a Murphy, Sean C |e verfasserin |4 aut | |
| 700 | 1 | |a Sim, B Kim Lee |e verfasserin |4 aut | |
| 700 | 1 | |a Vaughan, Ashley M |e verfasserin |4 aut | |
| 700 | 1 | |a Hoffman, Stephen L |e verfasserin |4 aut | |
| 700 | 1 | |a Kappe, Stefan Hi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t EMBO molecular medicine |d 2009 |g 16(2024), 4 vom: 09. Apr., Seite 723-754 |w (DE-627)NLM192618962 |x 1757-4684 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2024 |g number:4 |g day:09 |g month:04 |g pages:723-754 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s44321-024-00057-7 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2024 |e 4 |b 09 |c 04 |h 723-754 | ||